Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-012868

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 20, 2018P35,681$12.9227A2,834,793IBy Ltd Partnership
Common Stockholding———876,838D
Common StockF3holding———955,055IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right To Buy)F4$14.08Aug 20, 2018A25,000A—Aug 20, 2028Common Stock25,00025,000D

Explanation of responses